Cannabidiol-Induced Autophagy Ameliorates Tau Protein Clearance

Area of Science:

• Neuroscience
• Cell Biology
• Pharmacology

Background:

• Tau protein is crucial for microtubule stability but its abnormal accumulation is linked to neurodegenerative diseases.
• Autophagy, a cellular degradation pathway, is impaired in conditions with tau pathology.
• The cannabinoid system shows potential neuroprotective effects in neurodegenerative models.

Purpose of the Study:

• To investigate the effects of cannabidiol (CBD) on autophagy in human neuroblastoma cells overexpressing wild-type tau (EGFP-Tau WT).
• To determine if CBD-induced autophagy contributes to the degradation of tau protein.

Main Methods:

• Utilized a human neuroblastoma cell line (SH-SY5Y) with inducible expression of EGFP-Tau WT.
• Treated cells with varying concentrations of CBD and other cannabinoid receptor agonists (ACEA, GW-405,833).
• Assessed tau protein levels (AT8, total tau, EGFP-Tau WT fluorescence) and autophagy markers (LC3-II, autophagosome formation).
• Investigated the role of autophagy using chloroquine, an autophagy inhibitor.

Main Results:

• CBD treatment (100 nM and 10 µM) reduced AT8 and total tau expression.
• CBD increased the expression of LC3-II and autophagosome formation, indicating autophagy activation.
• CBD, ACEA, and GW-405,833 decreased EGFP-Tau WT fluorescence.
• Chloroquine treatment reversed the decrease in EGFP-Tau WT fluorescence induced by CBD and GW-405,833, confirming autophagy's role.

Conclusions:

• CBD effectively induces autophagy in cells expressing wild-type tau.
• This CBD-induced autophagy leads to increased degradation of tau protein.
• Cannabidiol demonstrates a potential neuroprotective role in a cellular model of neurodegeneration by modulating autophagy.